论文部分内容阅读
目的 Precision oncology aims to find the most beneficial therapeutic strategies for individual patients,and the optimized zPDX model generated by xenografting of human primary cancer cells into immune-compromised hosts and the microfluidic device,are promising tools for personalized drug screening in clinic.